Original Research
Published on 24 Feb 2022
Optimal Regimens and Clinical Breakpoint of Avilamycin Against Clostridium perfringens in Swine Based on PK-PD Study
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2022.769539
- 3,535 views
